177 related articles for article (PubMed ID: 15916218)
1. The stepwise approach to the treatment of melasma.
Perez MI
Cutis; 2005 Apr; 75(4):217-22. PubMed ID: 15916218
[TBL] [Abstract][Full Text] [Related]
2. Community-based trial of a triple-combination agent for the treatment of facial melasma.
Grimes P; Kelly AP; Torok H; Willis I
Cutis; 2006 Mar; 77(3):177-84. PubMed ID: 16610738
[TBL] [Abstract][Full Text] [Related]
3. Mandibular melasma.
Mandry Pagán R; Sánchez JL
P R Health Sci J; 2000 Sep; 19(3):231-4. PubMed ID: 11076368
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a new triple-combination agent for the treatment of facial melasma.
Taylor SC; Torok H; Jones T; Lowe N; Rich P; Tschen E; Menter A; Baumann L; Wieder JJ; Jarratt MM; Pariser D; Martin D; Weiss J; Shavin J; Ramirez N
Cutis; 2003 Jul; 72(1):67-72. PubMed ID: 12889718
[TBL] [Abstract][Full Text] [Related]
5. Improved quality of life with effective treatment of facial melasma: the pigment trial.
Balkrishnan R; Kelly AP; McMichael A; Torok H
J Drugs Dermatol; 2004; 3(4):377-81. PubMed ID: 15303781
[TBL] [Abstract][Full Text] [Related]
6. Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity.
Arellano I; Cestari T; Ocampo-Candiani J; Azulay-Abulafia L; Bezerra Trindade Neto P; Hexsel D; Machado-Pinto J; Muñoz H; Rivitti-Machado MC; Sittart JA; Trindade de Almeida AR; Rego V; Paliargues F; Marques-Hassun K
J Eur Acad Dermatol Venereol; 2012 May; 26(5):611-8. PubMed ID: 21623930
[TBL] [Abstract][Full Text] [Related]
7. Melasma in Latin America: options for therapy and treatment algorithm.
Cestari T; Arellano I; Hexsel D; Ortonne JP;
J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):760-72. PubMed ID: 19646135
[TBL] [Abstract][Full Text] [Related]
8. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies.
Breathnach AS
Cutis; 1996 Jan; 57(1 Suppl):36-45. PubMed ID: 8654129
[TBL] [Abstract][Full Text] [Related]
9. Raman spectroscopy analysis of the skin of patients with melasma before standard treatment with topical corticosteroids, retinoic acid, and hydroquinone mixture.
Moncada B; Castillo-Martínez C; Arenas E; León-Bejarano F; Ramírez-Elías MG; González FJ
Skin Res Technol; 2016 May; 22(2):170-3. PubMed ID: 26179661
[TBL] [Abstract][Full Text] [Related]
10. Treatment of mild to moderate facial melasma with the Lumixyl topical brightening system.
Hantash BM; Jimenez F
J Drugs Dermatol; 2012 May; 11(5):660-2. PubMed ID: 22527440
[TBL] [Abstract][Full Text] [Related]
11. Melasma.
Kauh YC; Zachian TF
Adv Exp Med Biol; 1999; 455():491-9. PubMed ID: 10599387
[TBL] [Abstract][Full Text] [Related]
12. Melasma: treatment with 10% tretinoin peeling mask.
Ghersetich I; Troiano M; Brazzini B; Arunachalam M; Lotti T
J Cosmet Dermatol; 2010 Jun; 9(2):117-21. PubMed ID: 20618557
[TBL] [Abstract][Full Text] [Related]
13. Combined trichloroacetic acid peel and topical ascorbic acid versus trichloroacetic acid peel alone in the treatment of melasma: a comparative study.
Soliman MM; Ramadan SA; Bassiouny DA; Abdelmalek M
J Cosmet Dermatol; 2007 Jun; 6(2):89-94. PubMed ID: 17524124
[TBL] [Abstract][Full Text] [Related]
14. Novel skin brightener used as monotherapy for moderate melasma in skin of color.
Grimes PE
J Drugs Dermatol; 2014 Mar; 13(3):364-6. PubMed ID: 24595584
[TBL] [Abstract][Full Text] [Related]
15. Skin-lightening effects of a new face care product in patients with melasma.
Scherdin U; Bürger A; Bielfeldt S; Filbry A; Weber T; Schölermann A; Wigger-Alberti W; Rippke F; Wilhelm KP
J Cosmet Dermatol; 2008 Mar; 7(1):68-75. PubMed ID: 18254815
[TBL] [Abstract][Full Text] [Related]
16. New and experimental treatments of cloasma and other hypermelanoses.
Picardo M; Carrera M
Dermatol Clin; 2007 Jul; 25(3):353-62, ix. PubMed ID: 17662901
[TBL] [Abstract][Full Text] [Related]
17. A histological examination for skin atrophy after 6 months of treatment with fluocinolone acetonide 0.01%, hydroquinone 4%, and tretinoin 0.05% cream.
Bhawan J; Grimes P; Pandya AG; Keady M; Byers HR; Guevara IL; Colón LE; Johnson LA; Gottschalk R
Am J Dermatopathol; 2009 Dec; 31(8):794-8. PubMed ID: 19755910
[TBL] [Abstract][Full Text] [Related]
18. Melasma--updated treatments.
Situm M; Kolić M; Bolanca Z; Ljubicić I; Misanović B
Coll Antropol; 2011 Sep; 35 Suppl 2():315-8. PubMed ID: 22220462
[TBL] [Abstract][Full Text] [Related]
19. Therapeutical approaches in melasma.
Prignano F; Ortonne JP; Buggiani G; Lotti T
Dermatol Clin; 2007 Jul; 25(3):337-42, viii. PubMed ID: 17662899
[TBL] [Abstract][Full Text] [Related]
20. The Therapeutic Use of Antioxidants for Melasma.
Babbush KM; Babbush RA; Khachemoune A
J Drugs Dermatol; 2020 Aug; 19(8):788-792. PubMed ID: 32845595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]